Movano Inc MOVE

NAS: MOVE | ISIN: US62459M1071   15/07/2025
0,697 USD (+26,70%)
(+26,70%)   15/07/2025

22 april 2025 · Movano Health's Proprietary Cuffless Blood Pressure Device Once Again Achieves Accuracy Commensurate with the FDA's Requirements · Persbericht

10 maart 2025 · Movano's Evie Ring Adds New Personalization and Trend Tracking to Support Women's Wellness Journey · Persbericht

3 september 2024 · Movano Health Advances to Final Phase of FDA Review Process for EvieMED Ring · Persbericht

14 augustus 2024 · Movano Health Reports Q2 2024 Financial Results and Provides Business Update · Persbericht

5 augustus 2024 · Movano Health to Report Second Quarter 2024 Financial Results on Wednesday August 14, 2024 · Persbericht

5 augustus 2024 · Movano Health Provides Progress Update on EvieMED Regulatory Filing · Persbericht

28 juni 2024 · Movano Health Announces Dr. Fatima Rodriguez Joining July 11 Virtual Event · Persbericht

13 juni 2024 · Movano Health Applies Advanced AI through Deep Learning to Deliver Improved Accuracy of Heart Rate in Motion · Persbericht

10 juni 2024 · MIT Selects Movano Health for Groundbreaking Study on Long COVID and Chronic Lyme Disease · Persbericht

15 mei 2024 · Movano Health Reports Q1 2024 Financial Results and Provides Business Update · Persbericht

9 mei 2024 · Movano Health Submits Exemplary Sp02 Clinical Trial Results in Key Step Towards FDA 510(k) Clearance Decision · Persbericht

6 mei 2024 · Movano Health to Report First Quarter 2024 Financial Results on Wednesday May 15, 2024 · Persbericht

5 april 2024 · Movano Health Closes $24 Million Private Placement · Persbericht

4 april 2024 · Movano Health Reports 2023 Financial Results and Provides Business Update · Persbericht

2 april 2024 · Movano Health Announces $24 Million Private Placement · Persbericht

2 april 2024 · Movano Health Secures Strategic Investment from Tier-One Multi-Billion Dollar Medical Device Company · Persbericht

2 april 2024 · Movano Health to Report Fourth Quarter 2023 Financial Results on Thursday, April 4, 2024 · Persbericht

14 maart 2024 · Evie Ring's Pulse Oximeter Exceeds FDA Accuracy Guidelines in Movano Health's Second Hypoxia Trial · Persbericht

22 januari 2024 · Movano Health Announces Evie Rings Now Shipping · Persbericht

9 januari 2024 · Movano Health and ams OSRAM Collaborate to Deliver Accurate Lifestyle Monitoring Solutions for Women · Persbericht

Mijn selecties